Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecules involved in T-cell costimulation

M K Jenkins1, J G Johnson

  • 1Department of Microbiology, University of Minnesota Medical School, Minneapolis 55455.

Current Opinion in Immunology
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anæsthetics Medico-Legally Considered.

The Dental register·2021
Same author

Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse.

Journal of immunological methods·2014
Same author

THE TOXIC EFFECTS OF GASOLINE FUMES.

Canadian Medical Association journal·2010
Same author

Gangrene of the Caecum and Colon in a Case of Acute Dysentery.

Canadian Medical Association journal·2010
Same author

The physiology of bacteria-free Trichomonas vaginalis.

The Journal of parasitology·2010
Same author

Suicide attempts and retrospective reports about parent-child relationships: evidence for the affectionless control hypothesis.

Psycho-social medicine·2009
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Maximal interleukin-2 gene expression in T cells requires costimulatory signals beyond T cell receptor activation. Manipulating the CD28-B7 interaction offers a way to control immune responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • T cell activation and interleukin-2 (IL-2) gene expression are critical for adaptive immunity.
  • While T cell receptor (TCR) signaling initiates T cell responses, maximal IL-2 expression requires additional signals.
  • The CD28 molecule on T cells provides a key costimulatory signal upon binding its ligand, B7, on antigen-presenting cells.

Purpose of the Study:

  • To investigate the role of the CD28-B7 costimulatory pathway in regulating T cell responses.
  • To explore the potential of modulating the CD28-B7 interaction for controlling immune responses.

Main Methods:

  • Experiments focused on analyzing the biochemical signals involved in T cell activation.
  • Studies examined the impact of the CD28-B7 interaction on interleukin-2 gene expression.

Related Experiment Videos

  • The effects of manipulating this interaction on overall immune responses were assessed.

    • Main Results:

    • The CD28-B7 interaction was confirmed to transduce a crucial costimulatory signal for T cells.
    • Evidence suggests that this interaction significantly influences the magnitude of T cell activation.
    • Experimental manipulation of the CD28-B7 pathway demonstrated its capacity to alter immune responses.

    Conclusions:

    • The CD28-B7 pathway is essential for maximal interleukin-2 gene expression and robust T cell activation.
    • Modulating the CD28-B7 interaction presents a promising strategy for therapeutic intervention in immune-related conditions.
    • Targeting this costimulatory pathway could lead to novel approaches for immune inhibition or augmentation.